Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

NCT02308111 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
334
Enrollment
INDUSTRY
Sponsor class

Stopped The DMC made the recommendation to not pursue further enrollment given the lack of feasibility for this post-marketing study as designed.

Conditions

Interventions

Sponsor

Intercept Pharmaceuticals